{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:17:16Z","timestamp":1790435836695,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112373","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T02:52:06Z","timestamp":1635389526000},"page":"112373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects"],"prefix":"10.1016","volume":"144","author":[{"given":"Eduardo Burgarelli","family":"Lages","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Salgado","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Mol Sena","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitchawat","family":"Paiyabhroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Barbosa","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovanni Dantas","family":"Cassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sicard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Lu\u00eds","family":"Branco de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Ant\u00f4nio Miranda","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112373_bib1","doi-asserted-by":"crossref","first-page":"44735","DOI":"10.1038\/srep44735","article-title":"Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112373_bib2","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2021.112373_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","article-title":"Doxorubicin: nanotechnological overviews from bench to bedside","volume":"22","author":"Cagel","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2021.112373_bib4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.biopha.2017.09.059","article-title":"A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer","volume":"95","author":"Shafei","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112373_bib5","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.biopha.2021.112373_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2021.112373_bib7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112373_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pharmaceutics12030288","article-title":"Nanostructured lipid carriers for delivery of chemotherapeutics: a review","volume":"12","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2021.112373_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110876","article-title":"Co-delivery of doxorubicin, docosahexaenoic acid, and \u03b1-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity","volume":"132","author":"Lages","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112373_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/biof.181","article-title":"Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects","volume":"37","author":"Siddiqui","year":"2011","journal-title":"BioFactors"},{"key":"10.1016\/j.biopha.2021.112373_bib11","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/ijms18122689","article-title":"Protective effects of \u03c9-3 PUFA in anthracycline-induced cardiotoxicity: a critical review","volume":"18","author":"Serini","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/07315724.2003.10719283","article-title":"\u03b1-tocopheryl succinate, the most effective form of vitamin e for adjuvant cancer treatment: a review","volume":"22","author":"Prasad","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.biopha.2021.112373_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.colsurfb.2015.12.019","article-title":"\u03b1-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles","volume":"140","author":"Oliveira","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2021.112373_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/bc400326y","article-title":"Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity","volume":"25","author":"Duhem","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2021.112373_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.colsurfb.2018.10.012","article-title":"A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy","volume":"173","author":"Xiong","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2021.112373_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201605985","article-title":"A drug-self-gated mesoporous antitumor nanoplatform based on pH-sensitive dynamic covalent bond","volume":"27","author":"Zeng","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2021.112373_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2016.12.011","article-title":"Hydrazone linkages in pH responsive drug delivery systems","volume":"99","author":"Sonawane","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib18","article-title":"Applications of surface modification technologies in nanomedicine for deep tumor penetration","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib19","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1021\/acsnano.9b04436","article-title":"Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine","volume":"13","author":"Cheng","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2021.112373_bib20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biopha.2018.04.139","article-title":"\u03b1- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo","volume":"103","author":"Fernandes","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112373_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2009.07.025","article-title":"Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles","volume":"381","author":"Castro","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112373_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejps.2012.10.025","article-title":"New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles","volume":"48","author":"Mussi","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2021.112373_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.biopha.2021.112373_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1152\/ajpheart.00573.2018","article-title":"Right coronary artery ligation in mice: a novel method to investigate right ventricular dysfunction and biventricular interaction","volume":"316","author":"Sicard","year":"2019","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.biopha.2021.112373_bib26","doi-asserted-by":"crossref","first-page":"44998","DOI":"10.1038\/srep44998","article-title":"Biodegradable polymeric nanocapsules prevent cardiotoxicity of anti-trypanosomal lychnopholide","volume":"7","author":"Branquinho","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112373_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105205","article-title":"Alpha-tocopheryl succinate improves encapsulation, pH-sensitivity, antitumor activity and reduces toxicity of doxorubicin-loaded liposomes","volume":"144","author":"Boratto","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib28","series-title":"Mouse Biomed. Res.","first-page":"133","article-title":"Hematology of the Laboratory Mouse","author":"Everds","year":"2007"},{"key":"10.1016\/j.biopha.2021.112373_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","article-title":"Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors","volume":"82","author":"duPre\u2019","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2021.112373_bib30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2021.112373_bib31","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1039\/C9NA00308H","article-title":"Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers","volume":"1","author":"Ristroph","year":"2019","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.biopha.2021.112373_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpb.2020.09.007","article-title":"Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids","volume":"156","author":"Gamboa","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2021.112373_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2016.01.049","article-title":"Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy","volume":"225","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2021.112373_bib34","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/sj.bjc.6601360","article-title":"Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity","volume":"89","author":"Neuzil","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2021.112373_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120457","article-title":"Vitamin E succinate with multiple functions: a versatile agent in nanomedicine-based cancer therapy and its delivery strategies","volume":"600","author":"Liang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112373_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/acs.biomac.7b01676","article-title":"CD44-targeted facile enzymatic activatable chitosan nanoparticles for efficient antitumor therapy and reversal of multidrug resistance","volume":"19","author":"Zhang","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biopha.2021.112373_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biomaterials.2015.05.046","article-title":"The self-assembling camptothecin-tocopherol prodrug: an effective approach for formulating camptothecin","volume":"62","author":"Lu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2021.112373_bib38","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejmech.2011.02.056","article-title":"Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities","volume":"46","author":"Chhikara","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.112373_bib39","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1021\/jm201653u","article-title":"Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate","volume":"55","author":"Chhikara","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.112373_bib40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/ijms17081257","article-title":"Docosahexaenoic acid induces oxidative DNA damage and apoptosis, and enhances the chemosensitivity of cancer cells","volume":"17","author":"Song","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jnutbio.2009.12.004","article-title":"Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids","volume":"21","author":"Adkins","year":"2010","journal-title":"J. Nutr. Biochem"},{"key":"10.1016\/j.biopha.2021.112373_bib42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2217\/nnm-2021-0128","article-title":"Nanomedicine to deliver docosahexaenoic acid: potential applications to improve health","volume":"16","author":"Lages","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2021.112373_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.lfs.2012.01.008","article-title":"Targeted therapy for cancer using pH-responsive nanocarrier systems","volume":"90","author":"Manchun","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib44","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/IJN.S120685","article-title":"Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers","volume":"12","author":"Ni","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2021.112373_bib45","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2217\/nnm-2017-0091","article-title":"Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model","volume":"12","author":"Dos Santos C\u00e2mara","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2021.112373_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109323","article-title":"Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model","volume":"118","author":"de Oliveira Silva","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112373_bib47","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3390\/ijms18102121","article-title":"Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment","volume":"18","author":"Pecoraro","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib48","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.2147\/IJN.S211130","article-title":"Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity","volume":"14","author":"Zhang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2021.112373_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.690533","article-title":"Nanomedicine in oncocardiology: contribution and perspectives of preclinical studies","volume":"8","author":"Borges","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2021.112373_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1389200218666170105165444","article-title":"Reduction of doxorubicin-induced cardiotoxicity using nanocarriers: a review","volume":"18","author":"Fojtu","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2021.112373_bib51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopha.2016.09.032","article-title":"Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy","volume":"84","author":"Fernandes","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112373_bib52","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/ijms18081784","article-title":"A critical review on the effect of docosahexaenoic acid (Dha) on cancer cell cycle progression","volume":"18","author":"Newell","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112373_bib53","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1538-7836.2009.03477.x","article-title":"Doxorubicin-induced platelet cytotoxicity: a new contributory factor for doxorubicin-mediated thrombocytopenia","volume":"7","author":"Kim","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2021.112373_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117599","article-title":"New molecular and biochemical insights of doxorubicin-induced hepatotoxicity","volume":"250","author":"Prasanna","year":"2020","journal-title":"Life Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:47:29Z","timestamp":1760100449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221011574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":54,"alternative-id":["S0753332221011574"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112373","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112373"}}